giography (MRA). The goal in the present study was to identify risk factors for the growth of UIAs detected by serial MRA in patients 70 years of age or older.
Methods

Patient Population
All protocols were reviewed and approved by the local institutional ethics committee. In this prospective study we enrolled 79 patients (age range 70-84 years) with 98 UIAs between April 2006 and March 2013. Inclusion criteria were a UIA ≥ 2 mm in diameter confirmed on MRA and/or 3D CT angiography (CTA) and the provision of informed consent. Exclusion criteria were symptoms from compression by the UIA; severe medical conditions, such as malignant neoplasm, cardiac failure, or renal failure requiring hemodialysis; and refusal to provide informed consent.
Of 163 UIAs (134 patients) examined in the study period, 65 aneurysms (55 patients) were excluded. Reasons for exclusion included compression of a cranial nerve or brain by the aneurysm (6 aneurysms, 6 patients); clipping surgery (20 aneurysms, 18 patients); aneurysms < 2 mm in size (27 aneurysms, 22 patients); severe medical conditions, such as malignant neoplasm, cardiac failure, or renal failure requiring hemodialysis (10 aneurysms, 7 patients); and refusal to participate in the study (2 aneurysms, 2 patients). Thus, this study included 98 aneurysms in 79 patients, including 21 men and 58 women, ranging in age from 70 to 84 years (mean age 73.9 ± 3.3 years).
Data gathered at the beginning of follow-up included patient sex, age, multiplicity of aneurysms, history of concomitant diseases (for example, hypertension, hyperlipidemia, diabetes mellitus, ischemic heart disease, cerebral infarction, hypertensive intracerebral hemorrhage [HICH] , aneurysmal subarachnoid hemorrhage [SAH] , current smoking status, family history of UIAs, and characteristics of UIAs [location, diameter]). Hypertension was defined as repeated episodes of systolic blood pressure ≥ 140 mm Hg or as diastolic pressure ≥ 90 mm Hg during visits to a family physician and/or the use of antihypertensive medication. Diabetes mellitus was diagnosed based on the presence of any one of the following: 1) fasting plasma glucose ≥ 126 mg/dl; 2) plasma glucose ≥ 200 mg/dl at 2 hours after a 75-g oral glucose load (that is, glucose tolerance test); 3) casual plasma glucose ≥ 200 mg/dl; or 4) hemoglobin A1c (HbA1c) ≥ 6.5%. Hyperlipidemia was defined as total cholesterol ≥ 240 mg/dl, lowdensity lipoprotein cholesterol ≥ 160 mg/dl, high-density lipoprotein cholesterol ≤ 35 mg/dl, or triglycerides ≥ 200 mg/dl. A family history of intracranial aneurysm was defined as any verified aneurysms in first-degree relatives. A contributor (Y.K.) to this study interviewed all patients while filling out a structured checklist. Two neurosurgeons (Y.K. and T.K.) measured aneurysm size on sagittal and axial MRA images. We categorized aneurysm growth into two different patterns on the basis of the MRA findings: 1) maximum aneurysm diameter increase by 2 mm or more; and 2) obvious morphological change, such as the appearance of a bleb. Three-dimensional CTA was used to confirm the exact size of aneurysms, but it was not used for follow-up examination. Three-dimensional CTA was performed after the injection of nonionic contrast material at a continuous flow of 2 ml/second and a total of 80-100 ml so that ≥ 250 intravascular HU could be obtained. Catheter-directed angiography was not performed for routine follow-up. If aneurysm growth was considered to have occurred during the course of observation, the subsequent treatment strategy was based on the policy at our institute. Indications for surgery for a UIA were based on the following Japanese Guidelines for the Management of Stroke 2004:
24 1) life expectancy > 15 years, 2) aneurysm size > 5 mm, or 3) aneurysm size < 5 mm in addition to an irregular shape, multiple lesions, large dome/neck ratio, family history, or anterior communicating artery (ACoA) aneurysm or internal carotid artery (ICA) to posterior communicating artery (PCoA) aneurysm. The risks and benefits of the procedures were reviewed with all patients. If the patient rejected surgical treatment, they were followed up every 4 months, including an assessment of the aneurysm diameter and morphological changes on MRA, neurological status, and other medical conditions. Nonsurgical treatments, such as medications, were allowed as needed. The major end point in this study was rupture or growth of the UIA. If patients refused further follow-up or failed to return because of other medical conditions, the follow-up periods for these cases were calculated as those from their registration until the last day of follow-up. Table 1 shows the baseline patient characteristics. Sixty-three patients (79.7%) had single UIAs, and 16 patients (20.3%) had multiple UIAs. Concomitant diseases included hypertension in 54 patients (68.4%), hyperlipidemia in 19 (24.1%), diabetes mellitus in 7 (8.9%), ischemic heart disease in 10 (12.6%), cerebral infarction in 12 (15.2%), HICH in 2 (2.5%), and SAH in 3 (3.8%). Fourteen patients (17.7%) were current smokers. Ten patients (12.6%) had a family history of intracranial aneurysm. Unruptured intracranial aneurysms were discovered for the following reasons: on brain checkups for headache, vertigo, numbness, and so forth in 62 patients (78.5%); in the course of examining cerebral infarction or HICH in 14 patients (17.7%); and in association with SAH in 3 patients (3.8%). The UIAs were located in the ICA in 25 cases (25.5%), the ACoA in 17 cases (17.3%), the anterior cerebral artery (ACA) in 4 cases (4.1%), the middle cerebral artery (MCA) in 45 cases (45.9%), and the vertebral or basilar artery in 7 cases (7.1%). The mean size of the UIAs was 4.9 ± 2.3 mm (range 2.0-13.1 mm).
Data Analysis
Patients were categorized into age groups of 70-74 years and ≥ 75 years. Univariate analyses to assess categorical variables (for example, sex, age ≥ 75 years, aneurysm multiplicity, history of concomitant disease, antiplatelet use, current smoking status, family history of UIA, and aneurysm location) and aneurysm growth were compared using the chi-square test. Aneurysm diameter in terms of aneurysm growth was compared using the Mann-Whitney U-test. Variables with a p < 0.05 were retained as covariates and entered together into the mul-tivariate Cox proportional-hazards regression model to identify independent predictive variables associated with future aneurysm growth. Differences were deemed statistically significant if p < 0.05. In the cases of aneurysm growth, follow-up periods were calculated from enrollment until the time of aneurysm growth detected on radiological examinations. The follow-up period was also expressed using the person-years method. The average annual risk of growth associated with UIAs was calculated by determining the number of first events of growth divided by the number of person-years of follow-up. The Kaplan-Meier product-limit method was used to estimate cumulative rates of growth.
Results
The mean duration of follow-up was 38.5 months (range 4-84 months), with a total of 250.2 patient-years of follow-up. Aneurysm rupture did not occur, but aneurysm growth was observed in 8 aneurysms (8 patients, all women). The characteristics of the patients with aneurysm growth are shown in Tables 2 and 3 . Growth and bleb formation were observed in 3 aneurysms (3 patients). The 8 women with aneurysm growth ranged in age from 72 to 79 years (median 76 years), and the aneurysms were located in the MCA in 5 cases and in the ICA in 3 cases. The maximum diameter of the lesions on admission ranged from 3.2 to 14.7 mm (mean 6.3 mm). Four patients underwent clipping for the aneurysm growth. Four patients preferred continuous observation and did not develop SAH during this period. Therefore, only 4 aneurysms (4 patients) met the inclusion criteria and underwent clipping surgery.
The remaining 94 aneurysms (75 patients) were not surgically repaired. The proportion of women and the proportion of patients with an age ≥ 75 years were significantly larger in the group with aneurysm growth than in the group without (p = 0.04 for both; Table 3 ). There was no significant difference in the proportion of patients with hypertension, hyperlipidemia, diabetes mellitus, ischemic heart disease, cerebral infarction, antiplatelet use, HICH, SAH, current smoking, or family history of UIA when comparing patients with and without aneurysm growth. Aneurysm location in the ICA or MCA was significantly more common in patients with aneurysm growth than in those without (p < 0.001). There was no significant difference in aneurysm diameter or multiplicity when comparing patients with and without aneurysm growth.
Since probability values for female sex, patient age ≥ 75 years, and ICA or MCA aneurysm were less than 0.05, these variables were entered as independent variables into the multivariate Cox proportional-hazards regression model (Table 4 ). This analysis demonstrated that female sex was the only independent predictor of aneurysm growth (p = 0.0313, OR 2.3, 95% CI 1.3-30.2).
In all patients, the 1-, 3-, 5-, and 7-year cumulative risks of aneurysm growth calculated using the KaplanMeier method were 2.8%, 7%, 15.3%, and 21.8%, respectively. In women, the 1-, 3-, 5-, and 7-year cumulative risks of aneurysm growth were 3.7%, 9%, 20.1%, and 28.3%, respectively.
Discussion
In the present study, univariate analysis suggested that female sex, patient age ≥ 75 years, and aneurysm location in the ICA or MCA were risk factors for the growth of UIAs in elderly patients. In a multivariate statistical analysis, the only independent risk factor for aneurysm growth was female sex. Our study demonstrated that aneurysms grew in 8 (10.1%) of 79 elderly patients. The growth rate of UIAs is expected to equal the rate in the present study (for example, 10.3%, 2 10.1%
18
) or to increase (for example, 6.7%, 25 6.4% 16 ) as the general population ages. Several previous studies, including autopsy reports, have demonstrated that the incidence of SAH or UIAs was 3-4 times higher in patients older than 70 years and that the prevalence of aneurysms increases with aging.
11, 23, 32 It is reasonable to suggest that factors associated with aging, such as prolonged exposure to hypertension, smoking, and atherosclerotic vessel degeneration, may contribute to an increased risk of aneurysm formation.
5
Although other factors, such as race or geographic location, may be involved, the present study indicates that growth is important in the natural history of unruptured aneurysms in elderly patients.
In this study, female sex was the only significant independent risk factor for aneurysm growth. Specifical ly, women may have an odds ratio (OR) as high as 2.3 for aneurysm growth as compared with men. Female sex has been previously described as a risk factor for aneurysm growth.
9,13 Aneurysm formation in women is thought to be attributable to hormonal factors.
14 Since estrogen is known to inhibit tumor necrosis factor-a activity 26 and the ex pression of adhesion molecules or chemo-attractants in vas cular smooth muscle cells, 7 reduced estrogen levels in postmenopausal women may predispose to a higher in cidence of aneurysm development because of a diminution in the collagen content in cerebral arteries. Experimental studies support this hypothesis. 12 In the present study, Kaplan-Meier analysis showed that the cumulative risk of growth at 1, 3, 5, and 7 years was 2.8%, 7%, 15.3%, and 21.8%, respectively, in all patients and 3.7%, 9%, 20.1%, and 28.3%, respectively, in women. This rapid increase in the proportion of aneurysms in elderly women displaying growth is another striking finding related to their natural course. This finding suggests that patients with nonsurgically treated aneurysms should be followed up over the long term to detect aneurysm growth that may require a modification in the treatment plan.
Patients 75 years of age or older had an increased risk of aneurysm growth according to univariate analyses. Our previous study suggested that surgical clipping of UIAs does not impair cognitive function and does relieve anxiety in patients ranging in age from 70 to 75 years, 15 which is consistent with other data obtained in patients younger than 70 years. 21, 22 Among the 20 aneurysms (18 patients) that were excluded because of clipping surgery, 16 of them (15 patients) occurred in patients ranging in age from 70 to 74 years. Therefore, patient selection bias could have been a confounding factor in this study.
Univariate analysis in the present study suggested that an aneurysm location in the ICA or MCA was a risk factor for aneurysm growth. While some studies suggest that ICA or MCA aneurysms tend to grow, 16, 18 other studies have indicated no site predilection for aneurysm growth.
2,3,9,13,25
The study of UIAs has strengthened the concept that chronic inflammation plays a significant role in aneurysm formation and potentially predisposes to aneurysm wall degeneration and rupture. 29 Aspirin has inhibitory effects on several inflammatory mediators postulated to play a role in cerebral aneurysm formation. Findings in the International Study of Unruptured Intracranial Aneurysms (ISUIA) cohort suggest that frequent aspirin use may confer a protective effect against intracranial aneurysm rupture. 8 In the present study, antiplatelet use was not associated with the growth of UIAs in elderly patients. However, further investigation is needed to confirm the effects of antiplatelet agents on aneurysm formation and growth.
This study has several limitations. First, because it was not a randomized study, patient selection bias cannot be ruled out. Our single-center study demonstrated that the incidence of UIAs in women was 73.4%. This rate is higher than those in multicenter prospective cohort studies or systematic reviews (for example, 66.5%, 20 63.6%, 25 
59.7% 19
). Identification of female sex as a risk factor for aneurysm growth in a multivariate analysis was based on a population in which three-quarters of the patients had that risk factor. Second, because of the relatively small number of enrolled patients, the number of participants in this clinical study may not be large enough for appropriate statistical analysis. In addition, because of the relatively short follow-up period (mean 38.5 months) and the relatively small sample numbers, the validity of predictions based on the generation of Kaplan-Meier curves is uncertain. Recent studies in rats have suggested that statins and angiotensin receptor blockers have an inhibitory effect on the development of intracranial aneurysms.
1, 27 The effect of these agents in elderly patients warrants further investigation.
Conclusions
In summary, female sex is an independent risk factor for the growth of UIAs in elderly patients. In addition, a patient age ≥ 75 years and an aneurysm location in the ICA or MCA may require additional attention with periodic imaging during follow-up. 
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